Cirrus Expands Ocular Immunology Through SERI Partnership
Cambridge, Massachusetts & Singapore, August 4, 2026 Cirrus Therapeutics has strengthened its position as an emerging ocular immunology biotechnology...
chronic wounds
Advertisement
AsymBio Secures $184 Million to Expand Global CDMO Growth
Shanghai, China, August 4, 2026 AsymBio, the biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem...
BioLab Publishes Membrane Wrap Study for Pressure Ulcers
Phoenix, Arizona, August 3, 2026 BioLab Holdings, Inc. has announced the publication of a peer-reviewed real-world evidence (RWE) study...
Organogenesis Publishes Positive Affinity Trial Results for Venous Leg Ulcers
CANTON, Mass., July 27, 2026 Organogenesis Holdings Inc. announced the publication of peer-reviewed clinical trial results demonstrating the effectiveness...
Merakris Therapeutics Wins NIH Funding for MTX-001
RESEARCH TRIANGLE PARK, N.C., July 21, 2026 Merakris Therapeutics announced that it has received a Direct-to-Phase II Small Business...
Advertisements
FibroBiologics Doses First Patients in Phase 1/2 Trial of CYWC628 for Diabetic Foot Ulcers
HOUSTON, June 16, 2026 FibroBiologics announced that the first patients have been dosed in its ongoing Phase 1/2 clinical...
FDA Clears Collagen Scaffold Device for Wound Care
ROSWELL, Ga., Feb. 12, 2026 — StimLabs announced that the U.S. Food and Drug Administration has granted 510(k) clearance...
Rapid Nexus Secures First FDA Clearance for Breakthrough Hemastyl® Wound-Healing Device
BREA, California — November 13, 2025: Rapid Nexus Nanotech Wound Solutions, Inc. has become the first company to receive...
FDA TRG Classifies Five Amniotic Membrane Allografts as HCT/Ps
PHOENIX, August 28, 2025 — Five amniotic membrane allograft products have received official recognition from the FDA’s Tissue Reference...
Advertisement
